Literature DB >> 28167321

Reply to: "Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C".

.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28167321     DOI： 10.1016/j.jhep.2017.01.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  2 in total

1.  Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study.

Authors:  Kelly Safreed-Harmon; Kristina L Hetherington; Soo Aleman; Hannu Alho; Olav Dalgard; Tove Frisch; Magnus Gottfredsson; Nina Weis; Jeffrey V Lazarus
Journal:  PLoS One       Date:  2018-01-30       Impact factor: 3.240

2.  Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.

Authors:  Jeffrey V Lazarus; Samya R Stumo; Magdalena Harris; Greet Hendrickx; Kristina L Hetherington; Mojca Maticic; Marie Jauffret-Roustide; Joan Tallada; Kaarlo Simojoki; Tatjana Reic; Kelly Safreed-Harmon
Journal:  J Int AIDS Soc       Date:  2018-04       Impact factor: 5.396
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.